Your browser doesn't support javascript.
loading
Adalimumab and myositis: A case report and review of the French and international Pharmacovigilance Databases.
Gaboriau, Louise; Davion, Jean-Baptiste; Combret, Sandrine; Lebrun-Vignes, Bénédicte; Rocher, Fanny; Rouby, Franck; Renaud, Florence; Morell-Dubois, Sandrine; Gautier, Sophie.
Afiliação
  • Gaboriau L; Centre régional de PharmacoVigilance, service de pharmacologie médicale, CHU Lille, 1, place de Verdun, F-59000 Lille, France. Electronic address: louise.gaboriau@chru-lille.fr.
  • Davion JB; Centre de référence des Maladies Neuromusculaires, CHU Lille, F-59000 Lille, France.
  • Combret S; Centre régional de pharmacovigilance, Vigilances - qualité - risques, CHU Dijon Bourgogne, F-21000 Dijon, France.
  • Lebrun-Vignes B; Centre régional de pharmacovigilance, Pharmacologie, Groupe Hospitalier Pitié-Salpêtrière, APHP, F-75000 Paris, France; EA 7379 EpidermE, Université Paris-Est Créteil, UPEC, F-94010 Créteil, France.
  • Rocher F; Centre régional de pharmacovigilance, CHU Nice, F-06000 Nice, France.
  • Rouby F; Centre régional de pharmacovigilance de Marseille Provence Corse, Assistance Publique, Hôpitaux de Marseille, F-13000 Marseille, France.
  • Renaud F; Centre de biologie pathologie, CHU Lille, F-59000 Lille, France.
  • Morell-Dubois S; Service de Médecine interne, CHU Lille, F-59000 Lille, France.
  • Gautier S; Centre régional de PharmacoVigilance, service de pharmacologie médicale, CHU Lille, 1, place de Verdun, F-59000 Lille, France.
Neuromuscul Disord ; 30(11): 915-920, 2020 11.
Article em En | MEDLINE | ID: mdl-33071068

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas de Notificação de Reações Adversas a Medicamentos / Farmacovigilância / Adalimumab / Anti-Inflamatórios / Miosite Limite: Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas de Notificação de Reações Adversas a Medicamentos / Farmacovigilância / Adalimumab / Anti-Inflamatórios / Miosite Limite: Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article